Comparative characteristic study from bone marrow-derived mesenchymal stem cells
- PMID: 34697921
- PMCID: PMC8636658
- DOI: 10.4142/jvs.2021.22.e74
Comparative characteristic study from bone marrow-derived mesenchymal stem cells
Abstract
Tissue engineering has been extensively investigated and proffered to be a potential platform for novel tissue regeneration. The utilization of mesenchymal stem cells (MSCs) from various sources has been widely explored and compared. In this regard, MSCs derived from bone marrow have been proposed and described as a promising cell resource due to their high yield of isolated cells with colony-forming potential, self-renewal capacity, MSC surface marker expression, and multi-lineage differentiation capacities in vitro. However, there is evidence for bone marrow MSCs (BM-MSCs) both in vitro and in vivo from different species presenting identical and distinct potential stemness characteristics. In this review, the fundamental knowledge of the growth kinetics and stemness properties of BM-MSCs in different animal species and humans are compared and summarized. Finally, to provide a full perspective, this review will procure results of current information studies focusing on the use of BM-MSCs in clinical practice.
Keywords: Tissue engineering; bone marrow mesenchymal stem cells; mesenchymal stem cells; stemness characteristics.
© 2021 The Korean Society of Veterinary Science.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9. Stem Cell Res Ther. 2017. PMID: 28446235 Free PMC article.
-
Comparative Craniofacial Bone Regeneration Capacities of Mesenchymal Stem Cells Derived from Human Neural Crest Stem Cells and Bone Marrow.ACS Biomater Sci Eng. 2021 Jan 11;7(1):207-221. doi: 10.1021/acsbiomaterials.0c00878. Epub 2020 Dec 9. ACS Biomater Sci Eng. 2021. PMID: 33455206
-
Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.Stem Cell Res Ther. 2017 Dec 6;8(1):275. doi: 10.1186/s13287-017-0716-x. Stem Cell Res Ther. 2017. PMID: 29208029 Free PMC article.
-
Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.Stem Cells Dev. 2012 Sep 20;21(14):2724-52. doi: 10.1089/scd.2011.0722. Epub 2012 May 9. Stem Cells Dev. 2012. PMID: 22468918 Review.
-
Human bone marrow mesenchymal stem cells in vivo.Rheumatology (Oxford). 2008 Feb;47(2):126-31. doi: 10.1093/rheumatology/kem206. Epub 2007 Nov 6. Rheumatology (Oxford). 2008. PMID: 17986482 Review.
Cited by
-
Physicochemical properties of bone marrow mesenchymal stem cells encapsulated in microcapsules combined with calcium phosphate cement and their ectopic bone formation.Front Bioeng Biotechnol. 2022 Oct 6;10:1005954. doi: 10.3389/fbioe.2022.1005954. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36277380 Free PMC article.
-
PHF8 promotes osteogenic differentiation of BMSCs in old rat with osteoporosis by regulating Wnt/β-catenin pathway.Open Life Sci. 2022 Dec 2;17(1):1591-1599. doi: 10.1515/biol-2022-0523. eCollection 2022. Open Life Sci. 2022. PMID: 36518887 Free PMC article.
-
Relationship of HIF‑1α expression with apoptosis and cell cycle in bone marrow mesenchymal stem cells from patients with myelodysplastic syndrome.Mol Med Rep. 2022 Jul;26(1):239. doi: 10.3892/mmr.2022.12755. Epub 2022 Jun 1. Mol Med Rep. 2022. PMID: 35642674 Free PMC article.
-
Evaluation of mesenchymal stem cells as an in vitro model for inherited retinal diseases.Front Cell Dev Biol. 2024 Nov 15;12:1455140. doi: 10.3389/fcell.2024.1455140. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39620144 Free PMC article. Review.
-
CYLD alleviates NLRP3 inflammasome-mediated pyroptosis in osteoporosis by deubiquitinating WNK1.J Orthop Surg Res. 2024 Apr 1;19(1):212. doi: 10.1186/s13018-024-04675-2. J Orthop Surg Res. 2024. PMID: 38561786 Free PMC article.
References
-
- de Isla N, Huseltein C, Jessel N, Pinzano A, Decot V, Magdalou J, et al. Introduction to tissue engineering and application for cartilage engineering. Biomed Mater Eng. 2010;20(3):127–133. - PubMed
-
- Gholami A, Dadkhah K, Anijdan SHM. Nanofiber and stem cell to bone, cartilage and muscle tissue engineering. Scholars Acad J Biosci. 2015;3(7):624–626.
-
- Yamzon JL, Kokorowski P, Koh CJ. Stem cells and tissue engineering applications of the genitourinary tract. Pediatr Res. 2008;63(5):472–477. - PubMed
-
- Berthiaume F, Maguire TJ, Yarmush ML. Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng. 2011;2(1):403–430. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources